
    
      The primary objective of the study is to determine the amount of lowering serum glucose as a
      function of dose of a topically applied formulation of Human Insulin administered by syringe
      measurement to adult Healthy Volunteer subjects as compared to no treatment. A 5-day period
      of daily blood sugar monitoring by means of wearable Continuous Glucose Monitor and insulin
      dosing for 3 days then monitoring for at least 3 days following will form the baseline and
      experiemental data for each subject.

      The secondary objective is to evaluate the tolerability and local and systemic effects of
      transdermal Human Insulin if any.
    
  